Fractyl Health (GUTS) Shares Outstanding (2023 - 2026)
Fractyl Health's (GUTS) quarterly Shares Outstanding (Entity) came in at $158.6 million in Q1 2026, up 224.3% YoY from $48.9 million in Q1 2025, and up 109.24% on a QoQ basis from $75.8 million in Q4 2025.
Fractyl Health (GUTS) Shares Outstanding (2023 - 2026) Analysis & Trends
Fractyl Health (GUTS) has 4 years of Shares Outstanding (Entity) data on file, last reported at $158.6 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 224.3% year-over-year to $158.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $158.6 million (up 224.3% YoY) and the FY2025 annual result came in at $75.8 million, up 55.51% from the prior year.
- Shares Outstanding (Entity) rose to $158.6 million in Q1 2026, from $75.8 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $158.6 million in Q1 2026 to a low of $2.1 million in Q1 2023.
- A 4-year average of $44.7 million and a median of $48.1 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) jumped 2215.28% — and 2025, when it climbed 4.18%.
- Tracing GUTS's Shares Outstanding (Entity) over 4 years: stood at $2.1 million in 2023, then jumped by 2215.28% to $48.8 million in 2024, then jumped by 55.51% to $75.8 million in 2025, then soared by 109.24% to $158.6 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $158.6 million (Q1 2026), $75.8 million (Q4 2025), and $64.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | Fractyl Health | 123.81 Mn | 123.81 Mn | - | 158.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 158.65 Mn |
| Mar 31, 2026 | 158.49 Mn |
| Dec 31, 2025 | 75.82 Mn |
| Sep 30, 2025 | 64.65 Mn |
| Jun 30, 2025 | 49.04 Mn |
| Mar 31, 2025 | 48.87 Mn |
| Dec 31, 2024 | 43.54 Mn |
| Sep 30, 2024 | 47.97 Mn |
| Jun 30, 2024 | 47.90 Mn |
| Mar 31, 2024 | 29.74 Mn |
| Dec 31, 2023 | 2.08 Mn |
| Sep 30, 2023 | 2.09 Mn |
| Jun 30, 2023 | 2.08 Mn |
| Mar 31, 2023 | 2.06 Mn |